amye O’Neal is the Lab Manager of Vanderbilt-Ingram Cancer Center’s Innovative Translational Research Shared Resource (ITR) at Vanderbilt University Medical Center (VUMC) in Nashville, TN. Prior to joining the ITR in 2011, she managed the TherapeUTex preclinical core in the Drug Dynamics Institute at the University of Texas at Austin’s College of Pharmacy from 2009-2011. […]
Month: April 2018
Vendor Focus – Cell Signaling Technologies
Take risks in your research, not your results. Scientific breakthroughs don’t come easy or often. That’s why Cell Signaling Technology (CST) is dedicated to helping you discover faster, frequently and more reliably with rigorously validated antibodies. Founded by research scientists in 1999, CST is a private, family-owned company with over 500 employees worldwide. We produce all of our antibodies in-house and […]
SEASR Spotlight – Angel Sampson
A scientific poster titled “Cross-Core Collaboration towards the Characterization of AAV-Antibody Complex Structures” presented at the recent ABRF Annual Meeting in Myrtle Beach proved to be a winner! The lead author on the poster is SEASR member Dr. Angel Sampson, Scientific Director of the Monoclonal Antibody Core at the ICBR, University of Florida in Gainesville. […]
